25 XP   0   0   10

Chenguang Biotech Group
Buy, Hold or Sell?

Let's analyse Chenguang Biotech Group together

PenkeI guess you are interested in Chenguang Biotech Group. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chenguang Biotech Group. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chenguang Biotech Group

I send you an email if I find something interesting about Chenguang Biotech Group.

Quick analysis of Chenguang Biotech Group (30 sec.)










What can you expect buying and holding a share of Chenguang Biotech Group? (30 sec.)

How much money do you get?

How much money do you get?
¥0.15
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.03
Expected worth in 1 year
¥9.27
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥4.31
Return On Investment
46.2%

For what price can you sell your share?

Current Price per Share
¥9.34
Expected price per share
¥0 - ¥11.16
How sure are you?
50%

1. Valuation of Chenguang Biotech Group (5 min.)




Live pricePrice per Share (EOD)

¥9.34

Intrinsic Value Per Share

¥3.01 - ¥16.33

Total Value Per Share

¥9.04 - ¥22.36

2. Growth of Chenguang Biotech Group (5 min.)




Is Chenguang Biotech Group growing?

Current yearPrevious yearGrowGrow %
How rich?$443.5m$384.1m$59.4m13.4%

How much money is Chenguang Biotech Group making?

Current yearPrevious yearGrowGrow %
Making money$59.8m$48.5m$11.3m19.0%
Net Profit Margin6.9%7.2%--

How much money comes from the company's main activities?

3. Financial Health of Chenguang Biotech Group (5 min.)




4. Comparing to competitors in the Farm Products industry (5 min.)




  Industry Rankings (Farm Products)  


Richest
#66 / 244

Most Revenue
#41 / 244

Most Profit
#26 / 244

What can you expect buying and holding a share of Chenguang Biotech Group? (5 min.)

Welcome investor! Chenguang Biotech Group's management wants to use your money to grow the business. In return you get a share of Chenguang Biotech Group.

What can you expect buying and holding a share of Chenguang Biotech Group?

First you should know what it really means to hold a share of Chenguang Biotech Group. And how you can make/lose money.

Speculation

The Price per Share of Chenguang Biotech Group is ¥9.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chenguang Biotech Group.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chenguang Biotech Group, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.03. Based on the TTM, the Book Value Change Per Share is ¥0.81 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.36 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.27 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chenguang Biotech Group.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.111.2%0.111.2%0.091.0%0.070.8%0.040.5%
Usd Book Value Change Per Share0.111.2%0.111.2%0.192.0%0.080.9%0.060.6%
Usd Dividend Per Share0.040.4%0.040.4%0.030.3%0.030.3%0.020.2%
Usd Total Gains Per Share0.151.6%0.151.6%0.222.3%0.111.2%0.070.8%
Usd Price Per Share2.45-2.45-2.30-1.84-1.92-
Price to Earnings Ratio21.76-21.76-25.31-25.38-116.08-
Price-to-Total Gains Ratio16.44-16.44-10.67-21.24-56.22-
Price to Book Ratio2.94-2.94-3.20-3.03-4.43-
Price-to-Total Gains Ratio16.44-16.44-10.67-21.24-56.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.28892
Number of shares775
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.110.08
Usd Total Gains Per Share0.150.11
Gains per Quarter (775 shares)115.3685.04
Gains per Year (775 shares)461.45340.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111634645185255330
2231692912170511670
3347103813732547661010
44621383183433910211350
55781729229542412771690
66942075275650915322030
78092421321759417882370
89252767367867820432710
910413113413976322983050
1011563458460084825543390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%15.01.00.093.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%

Fundamentals of Chenguang Biotech Group

About Chenguang Biotech Group

ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil; lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts; and grape seed oil, walnut oil, safflower seed oil, flaxseed oil, cottonseed oil, natural lutein, and dephenolized cottonseed protein products. Its products are primarily used in food, cosmetics, baking, beverages, health care, and feed industries. The company operates in Europe; the Americas; Australia; China, Russia, Japan, Korea, and other countries in Asia; and Africa. ChenGuang Biotech Group Co., Ltd. was incorporated in 2000 and is based in Quzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 12:31:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Chenguang Biotech Group.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chenguang Biotech Group earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • A Net Profit Margin of 6.9% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chenguang Biotech Group:

  • The MRQ is 6.9%. The company is making a profit. +1
  • The TTM is 6.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.9%TTM6.9%0.0%
TTM6.9%YOY7.2%-0.3%
TTM6.9%5Y6.3%+0.6%
5Y6.3%10Y4.9%+1.4%
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9%1.5%+5.4%
TTM6.9%1.8%+5.1%
YOY7.2%3.6%+3.6%
5Y6.3%2.4%+3.9%
10Y4.9%2.7%+2.2%
1.1.2. Return on Assets

Shows how efficient Chenguang Biotech Group is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • 6.3% Return on Assets means that Chenguang Biotech Group generated ¥0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chenguang Biotech Group:

  • The MRQ is 6.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.3%TTM6.3%0.0%
TTM6.3%YOY5.9%+0.4%
TTM6.3%5Y5.3%+1.0%
5Y5.3%10Y4.1%+1.2%
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3%0.4%+5.9%
TTM6.3%0.8%+5.5%
YOY5.9%1.3%+4.6%
5Y5.3%1.0%+4.3%
10Y4.1%1.1%+3.0%
1.1.3. Return on Equity

Shows how efficient Chenguang Biotech Group is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • 13.7% Return on Equity means Chenguang Biotech Group generated ¥0.14 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chenguang Biotech Group:

  • The MRQ is 13.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.7%TTM13.7%0.0%
TTM13.7%YOY12.6%+1.1%
TTM13.7%5Y11.7%+2.0%
5Y11.7%10Y8.2%+3.6%
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%1.2%+12.5%
TTM13.7%1.9%+11.8%
YOY12.6%2.6%+10.0%
5Y11.7%2.2%+9.5%
10Y8.2%2.3%+5.9%

1.2. Operating Efficiency of Chenguang Biotech Group.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chenguang Biotech Group is operating .

  • Measures how much profit Chenguang Biotech Group makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chenguang Biotech Group:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7.8%-7.8%
TTM-5Y6.2%-6.2%
5Y6.2%10Y5.0%+1.2%
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-3.0%
TTM-2.8%-2.8%
YOY7.8%4.9%+2.9%
5Y6.2%4.0%+2.2%
10Y5.0%3.8%+1.2%
1.2.2. Operating Ratio

Measures how efficient Chenguang Biotech Group is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Farm Products industry mean).
  • An Operation Ratio of 1.78 means that the operating costs are ¥1.78 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Chenguang Biotech Group:

  • The MRQ is 1.780. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.780. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.780TTM1.7800.000
TTM1.780YOY1.765+0.016
TTM1.7805Y1.763+0.017
5Y1.76310Y1.593+0.170
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7801.604+0.176
TTM1.7801.570+0.210
YOY1.7651.451+0.314
5Y1.7631.531+0.232
10Y1.5931.312+0.281

1.3. Liquidity of Chenguang Biotech Group.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chenguang Biotech Group is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Farm Products industry mean).
  • A Current Ratio of 1.79 means the company has ¥1.79 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Chenguang Biotech Group:

  • The MRQ is 1.787. The company is able to pay all its short-term debts. +1
  • The TTM is 1.787. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.787TTM1.7870.000
TTM1.787YOY1.483+0.304
TTM1.7875Y1.625+0.161
5Y1.62510Y1.441+0.184
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7871.562+0.225
TTM1.7871.599+0.188
YOY1.4831.688-0.205
5Y1.6251.696-0.071
10Y1.4411.532-0.091
1.3.2. Quick Ratio

Measures if Chenguang Biotech Group is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • A Quick Ratio of 0.12 means the company can pay off ¥0.12 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chenguang Biotech Group:

  • The MRQ is 0.116. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.116. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.116TTM0.1160.000
TTM0.116YOY0.147-0.031
TTM0.1165Y0.162-0.045
5Y0.16210Y0.206-0.044
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1160.389-0.273
TTM0.1160.431-0.315
YOY0.1470.533-0.386
5Y0.1620.555-0.393
10Y0.2060.571-0.365

1.4. Solvency of Chenguang Biotech Group.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chenguang Biotech Group assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chenguang Biotech Group to Farm Products industry mean.
  • A Debt to Asset Ratio of 0.54 means that Chenguang Biotech Group assets are financed with 53.6% credit (debt) and the remaining percentage (100% - 53.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chenguang Biotech Group:

  • The MRQ is 0.536. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.536. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.536TTM0.5360.000
TTM0.536YOY0.533+0.003
TTM0.5365Y0.544-0.008
5Y0.54410Y0.455+0.089
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5360.496+0.040
TTM0.5360.482+0.054
YOY0.5330.487+0.046
5Y0.5440.487+0.057
10Y0.4550.486-0.031
1.4.2. Debt to Equity Ratio

Measures if Chenguang Biotech Group is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • A Debt to Equity ratio of 117.2% means that company has ¥1.17 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chenguang Biotech Group:

  • The MRQ is 1.172. The company is able to pay all its debts with equity. +1
  • The TTM is 1.172. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.172TTM1.1720.000
TTM1.172YOY1.139+0.033
TTM1.1725Y1.215-0.043
5Y1.21510Y0.903+0.312
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1720.912+0.260
TTM1.1720.943+0.229
YOY1.1390.958+0.181
5Y1.2151.021+0.194
10Y0.9031.062-0.159

2. Market Valuation of Chenguang Biotech Group

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Chenguang Biotech Group generates.

  • Above 15 is considered overpriced but always compare Chenguang Biotech Group to the Farm Products industry mean.
  • A PE ratio of 21.76 means the investor is paying ¥21.76 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chenguang Biotech Group:

  • The EOD is 11.465. Based on the earnings, the company is underpriced. +1
  • The MRQ is 21.764. Based on the earnings, the company is fair priced.
  • The TTM is 21.764. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD11.465MRQ21.764-10.299
MRQ21.764TTM21.7640.000
TTM21.764YOY25.311-3.548
TTM21.7645Y25.378-3.615
5Y25.37810Y116.084-90.706
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
EOD11.4655.310+6.155
MRQ21.7646.023+15.741
TTM21.7648.443+13.321
YOY25.3116.821+18.490
5Y25.37811.281+14.097
10Y116.08413.727+102.357
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chenguang Biotech Group:

  • The EOD is 8.905. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 16.905. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 16.905. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD8.905MRQ16.905-8.000
MRQ16.905TTM16.9050.000
TTM16.905YOY-41.018+57.922
TTM16.9055Y11.345+5.560
5Y11.34510Y-4.829+16.174
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
EOD8.9050.932+7.973
MRQ16.9051.144+15.761
TTM16.9050.520+16.385
YOY-41.018-0.412-40.606
5Y11.345-1.629+12.974
10Y-4.829-1.023-3.806
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chenguang Biotech Group is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Farm Products industry mean).
  • A PB ratio of 2.94 means the investor is paying ¥2.94 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Chenguang Biotech Group:

  • The EOD is 1.548. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.939. Based on the equity, the company is underpriced. +1
  • The TTM is 2.939. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.548MRQ2.939-1.391
MRQ2.939TTM2.9390.000
TTM2.939YOY3.197-0.258
TTM2.9395Y3.028-0.089
5Y3.02810Y4.426-1.397
Compared to industry (Farm Products)
PeriodCompanyIndustry (mean)+/- 
EOD1.5481.293+0.255
MRQ2.9391.370+1.569
TTM2.9391.388+1.551
YOY3.1971.675+1.522
5Y3.0281.701+1.327
10Y4.4262.078+2.348
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Chenguang Biotech Group compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8080.8080%1.359-40%0.597+35%0.416+94%
Book Value Per Share--6.0336.0330%5.224+15%4.331+39%3.400+77%
Current Ratio--1.7871.7870%1.483+21%1.625+10%1.441+24%
Debt To Asset Ratio--0.5360.5360%0.533+1%0.544-2%0.455+18%
Debt To Equity Ratio--1.1721.1720%1.139+3%1.215-4%0.903+30%
Dividend Per Share--0.2700.2700%0.206+31%0.198+36%0.126+114%
Eps--0.8150.8150%0.660+23%0.523+56%0.325+151%
Free Cash Flow Per Share--1.0491.0490%-0.407+139%-0.019+102%-0.134+113%
Free Cash Flow To Equity Per Share--1.1221.1220%0.608+84%0.500+124%0.332+238%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--16.331--------
Intrinsic Value_10Y_min--3.007--------
Intrinsic Value_1Y_max--0.567--------
Intrinsic Value_1Y_min---0.025--------
Intrinsic Value_3Y_max--2.519--------
Intrinsic Value_3Y_min--0.208--------
Intrinsic Value_5Y_max--5.454--------
Intrinsic Value_5Y_min--0.747--------
Market Cap4976109309.440-90%9446083303.6809446083303.6800%8897326067.200+6%7119991949.824+33%7405564150.140+28%
Net Profit Margin--0.0690.0690%0.072-4%0.063+9%0.049+40%
Operating Margin----0%0.078-100%0.062-100%0.050-100%
Operating Ratio--1.7801.7800%1.765+1%1.763+1%1.593+12%
Pb Ratio1.548-90%2.9392.9390%3.197-8%3.028-3%4.426-34%
Pe Ratio11.465-90%21.76421.7640%25.311-14%25.378-14%116.084-81%
Price Per Share9.340-90%17.73017.7300%16.700+6%13.364+33%13.900+28%
Price To Free Cash Flow Ratio8.905-90%16.90516.9050%-41.018+343%11.345+49%-4.829+129%
Price To Total Gains Ratio8.659-90%16.43716.4370%10.673+54%21.244-23%56.217-71%
Quick Ratio--0.1160.1160%0.147-21%0.162-28%0.206-43%
Return On Assets--0.0630.0630%0.059+6%0.053+18%0.041+54%
Return On Equity--0.1370.1370%0.126+9%0.117+17%0.082+68%
Total Gains Per Share--1.0791.0790%1.565-31%0.795+36%0.542+99%
Usd Book Value--443543276.419443543276.4190%384106861.165+15%318456176.282+39%249962056.717+77%
Usd Book Value Change Per Share--0.1120.1120%0.187-40%0.082+35%0.057+94%
Usd Book Value Per Share--0.8330.8330%0.721+15%0.598+39%0.469+77%
Usd Dividend Per Share--0.0370.0370%0.028+31%0.027+36%0.017+114%
Usd Eps--0.1120.1120%0.091+23%0.072+56%0.045+151%
Usd Free Cash Flow--77111526.53277111526.5320%-29934305.971+139%-1418243.381+102%-8887159.243+112%
Usd Free Cash Flow Per Share--0.1450.1450%-0.056+139%-0.003+102%-0.019+113%
Usd Free Cash Flow To Equity Per Share--0.1550.1550%0.084+84%0.069+124%0.046+238%
Usd Market Cap686703084.703-90%1303559495.9081303559495.9080%1227830997.274+6%982558889.076+33%1021967852.719+28%
Usd Price Per Share1.289-90%2.4472.4470%2.305+6%1.844+33%1.918+28%
Usd Profit--59896580.80059896580.8000%48508991.172+23%38423189.116+56%23862765.221+151%
Usd Revenue--868830443.713868830443.7130%672558234.405+29%590946134.994+47%413718128.603+110%
Usd Total Gains Per Share--0.1490.1490%0.216-31%0.110+36%0.075+99%
 EOD+4 -4MRQTTM+0 -0YOY+23 -125Y+29 -610Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Chenguang Biotech Group based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.465
Price to Book Ratio (EOD)Between0-11.548
Net Profit Margin (MRQ)Greater than00.069
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.116
Current Ratio (MRQ)Greater than11.787
Debt to Asset Ratio (MRQ)Less than10.536
Debt to Equity Ratio (MRQ)Less than11.172
Return on Equity (MRQ)Greater than0.150.137
Return on Assets (MRQ)Greater than0.050.063
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Chenguang Biotech Group based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.219
Ma 20Greater thanMa 5010.377
Ma 50Greater thanMa 10011.134
Ma 100Greater thanMa 20011.793
OpenGreater thanClose9.220
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,923,740
Total Liabilities3,709,658
Total Stockholder Equity3,164,817
 As reported
Total Liabilities 3,709,658
Total Stockholder Equity+ 3,164,817
Total Assets = 6,923,740

Assets

Total Assets6,923,740
Total Current Assets4,926,773
Long-term Assets1,996,967
Total Current Assets
Cash And Cash Equivalents 1,146,657
Short-term Investments 17,581
Net Receivables 303,237
Inventory 2,033,381
Other Current Assets 1,324,967
Total Current Assets  (as reported)4,926,773
Total Current Assets  (calculated)4,825,821
+/- 100,951
Long-term Assets
Property Plant Equipment 1,538,371
Goodwill 594
Intangible Assets 315,047
Other Assets 56,858
Long-term Assets  (as reported)1,996,967
Long-term Assets  (calculated)1,910,870
+/- 86,097

Liabilities & Shareholders' Equity

Total Current Liabilities2,757,239
Long-term Liabilities952,419
Total Stockholder Equity3,164,817
Total Current Liabilities
Short Long Term Debt 2,043,262
Accounts payable 55,963
Other Current Liabilities 19,264
Total Current Liabilities  (as reported)2,757,239
Total Current Liabilities  (calculated)2,118,489
+/- 638,750
Long-term Liabilities
Long term Debt 770,000
Capital Lease Obligations Min Short Term Debt4,004
Other Liabilities 178,415
Deferred Long Term Liability 6,750
Long-term Liabilities  (as reported)952,419
Long-term Liabilities  (calculated)959,169
+/- 6,750
Total Stockholder Equity
Common Stock532,774
Retained Earnings 1,661,661
Total Stockholder Equity (as reported)3,164,817
Total Stockholder Equity (calculated)2,194,435
+/- 970,383
Other
Capital Stock532,774
Common Stock Shares Outstanding 532,774
Net Debt 1,666,606
Net Invested Capital 5,978,080
Net Tangible Assets 2,855,326
Net Working Capital 2,169,534
Property Plant and Equipment Gross 2,292,906



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
187,196
385,241
402,847
1,148,965
1,115,869
1,445,589
1,631,651
1,508,212
1,991,270
2,492,400
2,872,805
3,357,109
4,507,083
4,654,478
5,955,165
6,923,740
6,923,7405,955,1654,654,4784,507,0833,357,1092,872,8052,492,4001,991,2701,508,2121,631,6511,445,5891,115,8691,148,965402,847385,241187,196
   > Total Current Assets 
0
0
0
0
0
0
0
0
1,347,749
1,765,609
2,024,287
2,338,682
3,192,161
2,912,214
3,977,016
4,926,773
4,926,7733,977,0162,912,2143,192,1612,338,6822,024,2871,765,6091,347,74900000000
       Cash And Cash Equivalents 
3,621
8,619
36,658
426,181
150,255
37,351
83,041
134,497
306,263
266,845
127,304
192,913
547,823
309,775
732,593
1,146,657
1,146,657732,593309,775547,823192,913127,304266,845306,263134,49783,04137,351150,255426,18136,6588,6193,621
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
564
17,581
17,58156400000000000000
       Net Receivables 
48,668
99,538
50,248
97,038
157,180
104,256
134,530
100,643
153,029
270,514
231,884
309,252
308,253
313,056
393,602
303,237
303,237393,602313,056308,253309,252231,884270,514153,029100,643134,530104,256157,18097,03850,24899,53848,668
       Other Current Assets 
13,894
39,291
27,011
48,916
101,411
120,211
116,211
136,633
87,523
202,443
197,800
331,749
412,018
494,615
598,803
1,324,967
1,324,967598,803494,615412,018331,749197,800202,44387,523136,633116,211120,211101,41148,91627,01139,29113,894
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
726,791
848,518
1,018,427
1,314,922
1,742,264
1,978,150
1,996,967
1,996,9671,978,1501,742,2641,314,9221,018,427848,518726,791000000000
       Property Plant Equipment 
44,327
78,259
113,054
221,984
398,608
548,634
593,373
484,607
502,098
564,446
656,577
778,004
925,519
1,243,548
1,483,537
1,538,371
1,538,3711,483,5371,243,548925,519778,004656,577564,446502,098484,607593,373548,634398,608221,984113,05478,25944,327
       Goodwill 
0
0
0
0
0
0
0
594
594
594
594
594
594
594
594
594
5945945945945945945945945940000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
6,500
31,500
82,373
0
0
0
0
000082,37331,5006,500000000000
       Intangible Assets 
11,455
13,248
33,913
41,114
62,100
523
0
96,563
116,623
115,117
120,505
123,645
143,743
257,724
268,834
315,047
315,047268,834257,724143,743123,645120,505115,117116,62396,563052362,10041,11433,91313,24811,455
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
18,946
13,281
4,208
67,056
47,472
14,477
2,337
2,33714,47747,47267,0564,20813,28118,946000000000
> Total Liabilities 
85,495
237,306
192,173
215,917
147,163
447,730
641,263
499,690
564,119
967,458
1,248,882
1,616,921
2,766,003
2,594,943
3,171,782
3,709,658
3,709,6583,171,7822,594,9432,766,0031,616,9211,248,882967,458564,119499,690641,263447,730147,163215,917192,173237,30685,495
   > Total Current Liabilities 
81,000
232,208
184,369
210,745
136,294
425,236
583,335
444,986
506,921
912,297
1,196,024
1,555,782
2,433,067
1,425,972
2,682,053
2,757,239
2,757,2392,682,0531,425,9722,433,0671,555,7821,196,024912,297506,921444,986583,335425,236136,294210,745184,369232,20881,000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
644,600
891,878
1,279,170
1,939,751
0
0
0
0001,939,7511,279,170891,878644,600000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
644,600
891,878
1,279,170
1,939,751
1,037,743
1,838,742
2,043,262
2,043,2621,838,7421,037,7431,939,7511,279,170891,878644,600000000000
       Accounts payable 
22,796
107,927
30,127
20,898
35,466
82,368
44,873
54,888
57,159
86,014
71,089
97,858
272,301
27,636
34,295
55,963
55,96334,29527,636272,30197,85871,08986,01457,15954,88844,87382,36835,46620,89830,127107,92722,796
       Other Current Liabilities 
20,730
53,967
3,122
0
32,116
61,512
58,462
61,764
128,320
153,654
158,232
140,985
171,476
270,646
401,154
19,264
19,264401,154270,646171,476140,985158,232153,654128,32061,76458,46261,51232,11603,12253,96720,730
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
55,161
52,859
61,139
332,936
1,168,971
489,729
952,419
952,419489,7291,168,971332,93661,13952,85955,161000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
-644,600
-891,878
-1,279,170
-1,939,751
0
2,674
4,004
4,0042,6740-1,939,751-1,279,170-891,878-644,600000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
257,564
0
0
0
000257,564000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
2,000
1,800
2,038
3,675
4,453
4,118
3,926
6,750
6,7503,9264,1184,4533,6752,0381,8002,00000000000
> Total Stockholder Equity
88,840
126,863
188,110
905,252
955,134
994,875
987,362
1,007,204
1,416,503
1,503,034
1,624,997
1,744,121
1,748,100
2,064,141
2,785,483
3,164,817
3,164,8172,785,4832,064,1411,748,1001,744,1211,624,9971,503,0341,416,5031,007,204987,362994,875955,134905,252188,110126,86388,840
   Common Stock
50,000
50,000
66,785
89,785
89,785
179,571
179,571
179,571
216,571
262,110
366,954
513,707
511,868
520,313
532,774
532,774
532,774532,774520,313511,868513,707366,954262,110216,571179,571179,571179,57189,78589,78566,78550,00050,000
   Retained Earnings 
36,953
71,557
30,663
90,020
142,033
178,946
168,558
214,266
280,435
362,080
483,941
599,870
752,588
996,251
1,294,488
1,661,661
1,661,6611,294,488996,251752,588599,870483,941362,080280,435214,266168,558178,946142,03390,02030,66371,55736,953
   Capital Surplus 0000000000000000
   Treasury Stock00000-10,726-21,429000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
-22,657
-19,242
-23,755
-27,507
-28,147
26,915
-67,196
-51,425
-51,425-67,19626,915-28,147-27,507-23,755-19,242-22,65700000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,669,020
Cost of Revenue-5,811,973
Gross Profit857,047857,047
 
Operating Income (+$)
Gross Profit857,047
Operating Expense-6,103,878
Operating Income565,142-5,246,831
 
Operating Expense (+$)
Research Development91,972
Selling General Administrative77,384
Selling And Marketing Expenses-
Operating Expense6,103,878169,356
 
Net Interest Income (+$)
Interest Income10,155
Interest Expense-67,208
Other Finance Cost-1,166
Net Interest Income-55,887
 
Pretax Income (+$)
Operating Income565,142
Net Interest Income-55,887
Other Non-Operating Income Expenses-
Income Before Tax (EBT)586,612565,142
EBIT - interestExpense = -67,208
495,627
562,836
Interest Expense67,208
Earnings Before Interest and Taxes (EBIT)-653,820
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax586,612
Tax Provision-72,914
Net Income From Continuing Ops513,697513,697
Net Income495,627
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-55,887
 

Technical Analysis of Chenguang Biotech Group
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chenguang Biotech Group. The general trend of Chenguang Biotech Group is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chenguang Biotech Group's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chenguang Biotech Group.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.08 < 11.15 < 11.16.

The bearish price targets are: .

Tweet this
Chenguang Biotech Group Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chenguang Biotech Group. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chenguang Biotech Group Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chenguang Biotech Group. The current macd is -0.64699051.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chenguang Biotech Group price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Chenguang Biotech Group. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Chenguang Biotech Group price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Chenguang Biotech Group Daily Moving Average Convergence/Divergence (MACD) ChartChenguang Biotech Group Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chenguang Biotech Group. The current adx is 31.59.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Chenguang Biotech Group shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Chenguang Biotech Group Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chenguang Biotech Group. The current sar is 9.7793389.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Chenguang Biotech Group Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chenguang Biotech Group. The current rsi is 34.22. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Chenguang Biotech Group Daily Relative Strength Index (RSI) ChartChenguang Biotech Group Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chenguang Biotech Group. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chenguang Biotech Group price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Chenguang Biotech Group Daily Stochastic Oscillator ChartChenguang Biotech Group Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chenguang Biotech Group. The current cci is -63.69071268.

Chenguang Biotech Group Daily Commodity Channel Index (CCI) ChartChenguang Biotech Group Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chenguang Biotech Group. The current cmo is -30.92903931.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Chenguang Biotech Group Daily Chande Momentum Oscillator (CMO) ChartChenguang Biotech Group Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chenguang Biotech Group. The current willr is -84.11552347.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Chenguang Biotech Group Daily Williams %R ChartChenguang Biotech Group Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chenguang Biotech Group.

Chenguang Biotech Group Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chenguang Biotech Group. The current atr is 0.40701161.

Chenguang Biotech Group Daily Average True Range (ATR) ChartChenguang Biotech Group Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chenguang Biotech Group. The current obv is -134,316,525.

Chenguang Biotech Group Daily On-Balance Volume (OBV) ChartChenguang Biotech Group Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chenguang Biotech Group. The current mfi is 19.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Chenguang Biotech Group Daily Money Flow Index (MFI) ChartChenguang Biotech Group Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chenguang Biotech Group.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Chenguang Biotech Group Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chenguang Biotech Group based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.219
Ma 20Greater thanMa 5010.377
Ma 50Greater thanMa 10011.134
Ma 100Greater thanMa 20011.793
OpenGreater thanClose9.220
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chenguang Biotech Group with someone you think should read this too:
  • Are you bullish or bearish on Chenguang Biotech Group? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chenguang Biotech Group? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chenguang Biotech Group

I send you an email if I find something interesting about Chenguang Biotech Group.


Comments

How you think about this?

Leave a comment

Stay informed about Chenguang Biotech Group.

Receive notifications about Chenguang Biotech Group in your mailbox!